Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
Nat Commun
.
2023 Mar 22;14(1):1581.
doi: 10.1038/s41467-023-37367-2.
Authors
Youyi Fong
1
2
,
Yunda Huang
1
3
,
David Benkeser
4
,
Lindsay N Carpp
1
,
Germán Áñez
5
,
Wayne Woo
5
,
Alice McGarry
5
,
Lisa M Dunkle
5
,
Iksung Cho
5
,
Christopher R Houchens
6
,
Karen Martins
6
,
Lakshmi Jayashankar
6
,
Flora Castellino
6
,
Christos J Petropoulos
7
,
Andrew Leith
8
,
Deanne Haugaard
8
,
Bill Webb
8
,
Yiwen Lu
1
,
Chenchen Yu
1
,
Bhavesh Borate
1
,
Lars W P van der Laan
1
9
,
Nima S Hejazi
1
10
,
April K Randhawa
1
,
Michele P Andrasik
1
,
James G Kublin
1
,
Julia Hutter
11
,
Maryam Keshtkar-Jahromi
11
,
Tatiana H Beresnev
11
,
Lawrence Corey
1
12
,
Kathleen M Neuzil
13
,
Dean Follmann
14
,
Julie A Ake
15
,
Cynthia L Gay
16
,
Karen L Kotloff
13
,
Richard A Koup
#
17
,
Ruben O Donis
#
6
,
Peter B Gilbert
#
18
19
20
;
Immune Assays Team
;
Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team
;
United States Government (USG)/CoVPN Biostatistics Team
Affiliations
1
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
2
Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
3
Department of Global Health, University of Washington, Seattle, WA, 98195, USA.
4
Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
5
Novavax, Inc., Gaithersburg, MD, USA.
6
Biomedical Advanced Research and Development Authority, Washington, DC, USA.
7
LabCorp-Monogram Biosciences, South San Francisco, CA, USA.
8
Nexelis, Seattle, WA, USA.
9
Department of Statistics, University of Washington, Seattle, WA, USA.
10
Department of Biostatistics, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
11
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD, USA.
12
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
13
Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
14
Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
15
U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
16
University of North Carolina School of Medicine, Chapel Hill, NC, USA.
17
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
18
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. pgilbert@fredhutch.org.
19
Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. pgilbert@fredhutch.org.
20
Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA. pgilbert@fredhutch.org.
#
Contributed equally.
PMID:
36949083
PMCID:
PMC10031713
DOI:
10.1038/s41467-023-37367-2
No abstract available
Publication types
Published Erratum
Grants and funding
UM1 AI068635/AI/NIAID NIH HHS/United States